A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
- PMID: 9892621
- PMCID: PMC2192984
- DOI: 10.1084/jem.189.2.395
A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
Abstract
We have previously reported (Badolato, R., J.M. Wang, W.J. Murphy, A. R. Lloyd, D.F. Michiel, L.L. Bausserman, D.J. Kelvin, and J.J. Oppenheim. 1994. J. Exp. Med. 180:203; Xu, L., R. Badolato, W.J. Murphy, D.L. Longo, M. Anver, S. Hale, J.J. Oppenheim, and J.M. Wang. 1995. J. Immunol. 155:1184.) that the acute phase protein serum amyloid A (SAA) is a potent chemoattractant for human leukocytes in vitro and mouse phagocytes in vivo. To identify the signaling mechanisms, we evaluated patterns of cross-desensitization between SAA and other leukocyte chemoattractants. We found that the chemotactic bacterial peptide, N-formyl- methionyl-leucyl-phenylalanine (fMLP), was able to specifically attenuate Ca2+ mobilization in human phagocytes induced by SAA, but only at very high concentrations, suggesting that SAA uses a low affinity fMLP receptor. Here we demonstrate that SAA selectively induced Ca2+ mobilization and migration of HEK cells expressing FPRL1, a human seven-transmembrane domain phagocyte receptor with low affinity for fMLP, and high affinity for lipoxin A4. Furthermore, radiolabeled SAA specifically bound to human phagocytes and FPRL1-transfected 293 cells. In contrast, SAA was not a ligand or agonist for FPR, the high affinity fMLP receptor. Thus, SAA is the first chemotactic ligand identified for FPRL1. Our results suggest that FPRL1 mediates phagocyte migration in response to SAA.
Figures





Similar articles
-
T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.J Immunol. 1999 May 15;162(10):5924-30. J Immunol. 1999. PMID: 10229829
-
Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.J Immunol. 1999 Dec 15;163(12):6777-84. J Immunol. 1999. PMID: 10586077
-
Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.J Leukoc Biol. 2001 Jul;70(1):155-61. J Leukoc Biol. 2001. PMID: 11435499
-
Receptors for chemotactic formyl peptides as pharmacological targets.Int Immunopharmacol. 2002 Jan;2(1):1-13. doi: 10.1016/s1567-5769(01)00150-3. Int Immunopharmacol. 2002. PMID: 11789660 Review.
-
A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.Forum (Genova). 1999 Oct-Dec;9(4):299-314. Forum (Genova). 1999. PMID: 10611407 Review.
Cited by
-
Serum amyloid A promotes lung neutrophilia by increasing IL-17A levels in the mucosa and γδ T cells.Am J Respir Crit Care Med. 2013 Jul 15;188(2):179-86. doi: 10.1164/rccm.201211-2139OC. Am J Respir Crit Care Med. 2013. PMID: 23627303 Free PMC article.
-
Expression and signaling of formyl-peptide receptors in the brain.Neurochem Res. 2010 Dec;35(12):2018-26. doi: 10.1007/s11064-010-0301-5. Epub 2010 Nov 2. Neurochem Res. 2010. PMID: 21042851 Review.
-
Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways.Blood. 2011 Apr 7;117(14):3793-8. doi: 10.1182/blood-2010-11-318832. Epub 2011 Feb 16. Blood. 2011. PMID: 21325601 Free PMC article.
-
Serum amyloid A inhibits RANKL-induced osteoclast formation.Exp Mol Med. 2015 Nov 13;47(11):e194. doi: 10.1038/emm.2015.83. Exp Mol Med. 2015. PMID: 26563612 Free PMC article.
-
Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan.Am J Pathol. 2015 Oct;185(10):2641-52. doi: 10.1016/j.ajpath.2015.06.016. Am J Pathol. 2015. PMID: 26435412 Free PMC article.
References
-
- Sipe, J.D. 1990. The acute-phase response. In Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation. J.J. Oppenheim and E.M. Shevach, editors. Oxford University Press, New York. 259–273.
-
- Kisilevsky R. Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism. Med Hypotheses. 1991;35:337–341. - PubMed
-
- Skinner M. Protein AA/SAA. J Intern Med. 1992;232:513–514. - PubMed
-
- Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26:427–435. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous